nodes	percent_of_prediction	percent_of_DWPC	metapath
Gemfibrozil—PPAR alpha—Pioglitazone—type 2 diabetes mellitus	0.363	1	CiPCiCtD
Gemfibrozil—coronary artery disease—type 2 diabetes mellitus	0.232	1	CtDrD
Gemfibrozil—PPARA—type 2 diabetes mellitus	0.099	0.658	CbGaD
Gemfibrozil—CYP1A2—type 2 diabetes mellitus	0.0309	0.205	CbGaD
Gemfibrozil—CYP3A4—type 2 diabetes mellitus	0.0204	0.136	CbGaD
Gemfibrozil—SLCO1B1—Repaglinide—type 2 diabetes mellitus	0.0129	0.0734	CbGbCtD
Gemfibrozil—SLCO1B1—Pioglitazone—type 2 diabetes mellitus	0.0117	0.0664	CbGbCtD
Gemfibrozil—SLCO1B1—Rosiglitazone—type 2 diabetes mellitus	0.0108	0.0612	CbGbCtD
Gemfibrozil—SLCO1B1—Valsartan—type 2 diabetes mellitus	0.00951	0.0541	CbGbCtD
Gemfibrozil—CYP2C8—Sitagliptin—type 2 diabetes mellitus	0.00683	0.0388	CbGbCtD
Gemfibrozil—SLCO1B1—Losartan—type 2 diabetes mellitus	0.00546	0.0311	CbGbCtD
Gemfibrozil—CYP2C8—Repaglinide—type 2 diabetes mellitus	0.00546	0.0311	CbGbCtD
Gemfibrozil—CYP2C8—Pioglitazone—type 2 diabetes mellitus	0.00493	0.0281	CbGbCtD
Gemfibrozil—CYP2C19—Gliclazide—type 2 diabetes mellitus	0.00487	0.0277	CbGbCtD
Gemfibrozil—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.00476	0.0271	CbGbCtD
Gemfibrozil—CYP2C8—Rosiglitazone—type 2 diabetes mellitus	0.00455	0.0259	CbGbCtD
Gemfibrozil—CYP2C8—Tolbutamide—type 2 diabetes mellitus	0.0044	0.025	CbGbCtD
Gemfibrozil—CYP2C9—Glipizide—type 2 diabetes mellitus	0.00435	0.0248	CbGbCtD
Gemfibrozil—CYP2C19—Pioglitazone—type 2 diabetes mellitus	0.00414	0.0236	CbGbCtD
Gemfibrozil—CYP2C19—Chlorpropamide—type 2 diabetes mellitus	0.00414	0.0236	CbGbCtD
Gemfibrozil—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.00405	0.023	CbGbCtD
Gemfibrozil—CYP2C19—Rosiglitazone—type 2 diabetes mellitus	0.00382	0.0217	CbGbCtD
Gemfibrozil—CYP2C19—Tolbutamide—type 2 diabetes mellitus	0.00369	0.021	CbGbCtD
Gemfibrozil—CYP2C8—Irbesartan—type 2 diabetes mellitus	0.00359	0.0204	CbGbCtD
Gemfibrozil—CYP1A2—Rosiglitazone—type 2 diabetes mellitus	0.00353	0.0201	CbGbCtD
Gemfibrozil—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.00344	0.0196	CbGbCtD
Gemfibrozil—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.00344	0.0196	CbGbCtD
Gemfibrozil—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.00318	0.0181	CbGbCtD
Gemfibrozil—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.00311	0.0177	CbGbCtD
Gemfibrozil—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.00307	0.0175	CbGbCtD
Gemfibrozil—CYP2C9—Valsartan—type 2 diabetes mellitus	0.00281	0.016	CbGbCtD
Gemfibrozil—CYP1A2—Irbesartan—type 2 diabetes mellitus	0.00278	0.0158	CbGbCtD
Gemfibrozil—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.00277	0.0158	CbGbCtD
Gemfibrozil—CYP1A2—Bromocriptine—type 2 diabetes mellitus	0.00262	0.0149	CbGbCtD
Gemfibrozil—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.00261	0.0148	CbGbCtD
Gemfibrozil—CYP3A4—Glipizide—type 2 diabetes mellitus	0.00253	0.0144	CbGbCtD
Gemfibrozil—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.0025	0.0142	CbGbCtD
Gemfibrozil—CYP2C8—Losartan—type 2 diabetes mellitus	0.00231	0.0131	CbGbCtD
Gemfibrozil—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.00221	0.0126	CbGbCtD
Gemfibrozil—CYP2C19—Glyburide—type 2 diabetes mellitus	0.00212	0.0121	CbGbCtD
Gemfibrozil—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.002	0.0114	CbGbCtD
Gemfibrozil—CYP2C19—Losartan—type 2 diabetes mellitus	0.00194	0.011	CbGbCtD
Gemfibrozil—CYP1A2—Losartan—type 2 diabetes mellitus	0.00179	0.0102	CbGbCtD
Gemfibrozil—CYP2C9—Glyburide—type 2 diabetes mellitus	0.00176	0.01	CbGbCtD
Gemfibrozil—PPARA—brown adipose tissue—type 2 diabetes mellitus	0.00162	0.431	CbGeAlD
Gemfibrozil—CYP2C9—Losartan—type 2 diabetes mellitus	0.00161	0.00917	CbGbCtD
Gemfibrozil—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00152	0.00863	CbGbCtD
Gemfibrozil—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00145	0.00828	CbGbCtD
Gemfibrozil—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00145	0.00828	CbGbCtD
Gemfibrozil—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00138	0.00783	CbGbCtD
Gemfibrozil—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00102	0.00583	CbGbCtD
Gemfibrozil—CYP3A4—Losartan—type 2 diabetes mellitus	0.000937	0.00533	CbGbCtD
Gemfibrozil—Bupranolol—ADRB3—type 2 diabetes mellitus	0.000775	1	CrCbGaD
Gemfibrozil—PPARA—retina—type 2 diabetes mellitus	0.000293	0.0781	CbGeAlD
Gemfibrozil—PPARA—cardiovascular system—type 2 diabetes mellitus	0.000248	0.066	CbGeAlD
Gemfibrozil—PPARA—kidney—type 2 diabetes mellitus	0.000242	0.0646	CbGeAlD
Gemfibrozil—PPARA—pancreas—type 2 diabetes mellitus	0.000241	0.0642	CbGeAlD
Gemfibrozil—PPARA—adipose tissue—type 2 diabetes mellitus	0.000219	0.0582	CbGeAlD
Gemfibrozil—SLCO1B1—kidney—type 2 diabetes mellitus	0.000155	0.0412	CbGeAlD
Gemfibrozil—PPARA—liver—type 2 diabetes mellitus	0.000153	0.0408	CbGeAlD
Gemfibrozil—SLCO1B1—liver—type 2 diabetes mellitus	9.77e-05	0.026	CbGeAlD
Gemfibrozil—CYP2C8—kidney—type 2 diabetes mellitus	8.79e-05	0.0234	CbGeAlD
Gemfibrozil—CYP2C9—cardiovascular system—type 2 diabetes mellitus	7.98e-05	0.0213	CbGeAlD
Gemfibrozil—CYP2C19—liver—type 2 diabetes mellitus	6.37e-05	0.017	CbGeAlD
Gemfibrozil—CYP3A4—kidney—type 2 diabetes mellitus	5.95e-05	0.0159	CbGeAlD
Gemfibrozil—CYP2C8—liver—type 2 diabetes mellitus	5.56e-05	0.0148	CbGeAlD
Gemfibrozil—CYP1A2—liver—type 2 diabetes mellitus	5.2e-05	0.0139	CbGeAlD
Gemfibrozil—CYP2C9—liver—type 2 diabetes mellitus	4.94e-05	0.0132	CbGeAlD
Gemfibrozil—CYP3A4—liver—type 2 diabetes mellitus	3.76e-05	0.01	CbGeAlD
Gemfibrozil—Headache—Glipizide—type 2 diabetes mellitus	3.39e-05	0.000708	CcSEcCtD
Gemfibrozil—Shock—Valsartan—type 2 diabetes mellitus	3.38e-05	0.000706	CcSEcCtD
Gemfibrozil—Loss of consciousness—Metformin—type 2 diabetes mellitus	3.37e-05	0.000704	CcSEcCtD
Gemfibrozil—Nervous system disorder—Valsartan—type 2 diabetes mellitus	3.37e-05	0.000704	CcSEcCtD
Gemfibrozil—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	3.37e-05	0.000703	CcSEcCtD
Gemfibrozil—Paraesthesia—Gliclazide—type 2 diabetes mellitus	3.36e-05	0.000702	CcSEcCtD
Gemfibrozil—Flatulence—Losartan—type 2 diabetes mellitus	3.36e-05	0.000701	CcSEcCtD
Gemfibrozil—Anaemia—Irbesartan—type 2 diabetes mellitus	3.35e-05	0.000699	CcSEcCtD
Gemfibrozil—Tension—Losartan—type 2 diabetes mellitus	3.35e-05	0.000698	CcSEcCtD
Gemfibrozil—Dizziness—Glimepiride—type 2 diabetes mellitus	3.34e-05	0.000698	CcSEcCtD
Gemfibrozil—Skin disorder—Valsartan—type 2 diabetes mellitus	3.34e-05	0.000697	CcSEcCtD
Gemfibrozil—Dysgeusia—Losartan—type 2 diabetes mellitus	3.34e-05	0.000697	CcSEcCtD
Gemfibrozil—Nervous system disorder—Orlistat—type 2 diabetes mellitus	3.33e-05	0.000696	CcSEcCtD
Gemfibrozil—Dizziness—Sitagliptin—type 2 diabetes mellitus	3.33e-05	0.000696	CcSEcCtD
Gemfibrozil—Somnolence—Gliclazide—type 2 diabetes mellitus	3.33e-05	0.000695	CcSEcCtD
Gemfibrozil—Urticaria—Glyburide—type 2 diabetes mellitus	3.31e-05	0.000691	CcSEcCtD
Gemfibrozil—Nervousness—Losartan—type 2 diabetes mellitus	3.31e-05	0.000691	CcSEcCtD
Gemfibrozil—Angioedema—Irbesartan—type 2 diabetes mellitus	3.31e-05	0.000691	CcSEcCtD
Gemfibrozil—Skin disorder—Orlistat—type 2 diabetes mellitus	3.3e-05	0.000689	CcSEcCtD
Gemfibrozil—Connective tissue disorder—Ramipril—type 2 diabetes mellitus	3.3e-05	0.000689	CcSEcCtD
Gemfibrozil—Abdominal pain—Glyburide—type 2 diabetes mellitus	3.3e-05	0.000688	CcSEcCtD
Gemfibrozil—Dyspepsia—Gliclazide—type 2 diabetes mellitus	3.3e-05	0.000688	CcSEcCtD
Gemfibrozil—Asthenia—Bromocriptine—type 2 diabetes mellitus	3.27e-05	0.000683	CcSEcCtD
Gemfibrozil—Myalgia—Metformin—type 2 diabetes mellitus	3.27e-05	0.000682	CcSEcCtD
Gemfibrozil—Chest pain—Metformin—type 2 diabetes mellitus	3.27e-05	0.000682	CcSEcCtD
Gemfibrozil—Vertigo—Irbesartan—type 2 diabetes mellitus	3.25e-05	0.000679	CcSEcCtD
Gemfibrozil—Headache—Pioglitazone—type 2 diabetes mellitus	3.25e-05	0.000679	CcSEcCtD
Gemfibrozil—Syncope—Irbesartan—type 2 diabetes mellitus	3.25e-05	0.000678	CcSEcCtD
Gemfibrozil—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	3.25e-05	0.000677	CcSEcCtD
Gemfibrozil—Leukopenia—Irbesartan—type 2 diabetes mellitus	3.24e-05	0.000677	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	3.23e-05	0.000675	CcSEcCtD
Gemfibrozil—Fatigue—Gliclazide—type 2 diabetes mellitus	3.23e-05	0.000674	CcSEcCtD
Gemfibrozil—Nausea—Glipizide—type 2 diabetes mellitus	3.22e-05	0.000672	CcSEcCtD
Gemfibrozil—Vomiting—Glimepiride—type 2 diabetes mellitus	3.22e-05	0.000671	CcSEcCtD
Gemfibrozil—Vision blurred—Losartan—type 2 diabetes mellitus	3.21e-05	0.000671	CcSEcCtD
Gemfibrozil—Vomiting—Sitagliptin—type 2 diabetes mellitus	3.2e-05	0.000669	CcSEcCtD
Gemfibrozil—Constipation—Gliclazide—type 2 diabetes mellitus	3.2e-05	0.000668	CcSEcCtD
Gemfibrozil—Pain—Gliclazide—type 2 diabetes mellitus	3.2e-05	0.000668	CcSEcCtD
Gemfibrozil—Rash—Glimepiride—type 2 diabetes mellitus	3.19e-05	0.000665	CcSEcCtD
Gemfibrozil—Dermatitis—Glimepiride—type 2 diabetes mellitus	3.19e-05	0.000665	CcSEcCtD
Gemfibrozil—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	3.18e-05	0.000665	CcSEcCtD
Gemfibrozil—Rash—Sitagliptin—type 2 diabetes mellitus	3.18e-05	0.000663	CcSEcCtD
Gemfibrozil—Dermatitis—Sitagliptin—type 2 diabetes mellitus	3.18e-05	0.000663	CcSEcCtD
Gemfibrozil—Headache—Glimepiride—type 2 diabetes mellitus	3.17e-05	0.000661	CcSEcCtD
Gemfibrozil—Cough—Irbesartan—type 2 diabetes mellitus	3.16e-05	0.00066	CcSEcCtD
Gemfibrozil—Headache—Sitagliptin—type 2 diabetes mellitus	3.16e-05	0.000659	CcSEcCtD
Gemfibrozil—Anaemia—Losartan—type 2 diabetes mellitus	3.15e-05	0.000658	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	3.13e-05	0.000654	CcSEcCtD
Gemfibrozil—Oedema—Metformin—type 2 diabetes mellitus	3.13e-05	0.000654	CcSEcCtD
Gemfibrozil—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	3.12e-05	0.000651	CcSEcCtD
Gemfibrozil—Angioedema—Losartan—type 2 diabetes mellitus	3.12e-05	0.00065	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	3.1e-05	0.000646	CcSEcCtD
Gemfibrozil—Paraesthesia—Valsartan—type 2 diabetes mellitus	3.09e-05	0.000645	CcSEcCtD
Gemfibrozil—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	3.09e-05	0.000644	CcSEcCtD
Gemfibrozil—Arthralgia—Irbesartan—type 2 diabetes mellitus	3.08e-05	0.000644	CcSEcCtD
Gemfibrozil—Chest pain—Irbesartan—type 2 diabetes mellitus	3.08e-05	0.000644	CcSEcCtD
Gemfibrozil—Myalgia—Irbesartan—type 2 diabetes mellitus	3.08e-05	0.000644	CcSEcCtD
Gemfibrozil—Shock—Metformin—type 2 diabetes mellitus	3.08e-05	0.000643	CcSEcCtD
Gemfibrozil—Nervous system disorder—Metformin—type 2 diabetes mellitus	3.07e-05	0.000641	CcSEcCtD
Gemfibrozil—Thrombocytopenia—Metformin—type 2 diabetes mellitus	3.07e-05	0.00064	CcSEcCtD
Gemfibrozil—Vertigo—Losartan—type 2 diabetes mellitus	3.06e-05	0.000639	CcSEcCtD
Gemfibrozil—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	3.06e-05	0.000639	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	3.06e-05	0.000639	CcSEcCtD
Gemfibrozil—Somnolence—Valsartan—type 2 diabetes mellitus	3.06e-05	0.000638	CcSEcCtD
Gemfibrozil—Syncope—Losartan—type 2 diabetes mellitus	3.06e-05	0.000638	CcSEcCtD
Gemfibrozil—Paraesthesia—Orlistat—type 2 diabetes mellitus	3.05e-05	0.000637	CcSEcCtD
Gemfibrozil—Leukopenia—Losartan—type 2 diabetes mellitus	3.05e-05	0.000637	CcSEcCtD
Gemfibrozil—Skin disorder—Metformin—type 2 diabetes mellitus	3.04e-05	0.000635	CcSEcCtD
Gemfibrozil—Dyspepsia—Valsartan—type 2 diabetes mellitus	3.03e-05	0.000632	CcSEcCtD
Gemfibrozil—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	3.03e-05	0.000632	CcSEcCtD
Gemfibrozil—Dizziness—Bromocriptine—type 2 diabetes mellitus	3.02e-05	0.00063	CcSEcCtD
Gemfibrozil—Nausea—Glimepiride—type 2 diabetes mellitus	3e-05	0.000627	CcSEcCtD
Gemfibrozil—Loss of consciousness—Losartan—type 2 diabetes mellitus	3e-05	0.000625	CcSEcCtD
Gemfibrozil—Nausea—Sitagliptin—type 2 diabetes mellitus	2.99e-05	0.000625	CcSEcCtD
Gemfibrozil—Dyspepsia—Orlistat—type 2 diabetes mellitus	2.99e-05	0.000625	CcSEcCtD
Gemfibrozil—Asthenia—Glyburide—type 2 diabetes mellitus	2.99e-05	0.000624	CcSEcCtD
Gemfibrozil—Cough—Losartan—type 2 diabetes mellitus	2.97e-05	0.000621	CcSEcCtD
Gemfibrozil—Urticaria—Gliclazide—type 2 diabetes mellitus	2.97e-05	0.000621	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	2.97e-05	0.00062	CcSEcCtD
Gemfibrozil—Alopecia—Ramipril—type 2 diabetes mellitus	2.97e-05	0.000619	CcSEcCtD
Gemfibrozil—Fatigue—Valsartan—type 2 diabetes mellitus	2.97e-05	0.000619	CcSEcCtD
Gemfibrozil—Abdominal pain—Gliclazide—type 2 diabetes mellitus	2.96e-05	0.000618	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	2.96e-05	0.000617	CcSEcCtD
Gemfibrozil—Oedema—Irbesartan—type 2 diabetes mellitus	2.96e-05	0.000617	CcSEcCtD
Gemfibrozil—Pruritus—Glyburide—type 2 diabetes mellitus	2.95e-05	0.000616	CcSEcCtD
Gemfibrozil—Mental disorder—Ramipril—type 2 diabetes mellitus	2.94e-05	0.000614	CcSEcCtD
Gemfibrozil—Constipation—Valsartan—type 2 diabetes mellitus	2.94e-05	0.000614	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	2.93e-05	0.000613	CcSEcCtD
Gemfibrozil—Fatigue—Orlistat—type 2 diabetes mellitus	2.93e-05	0.000612	CcSEcCtD
Gemfibrozil—Shock—Irbesartan—type 2 diabetes mellitus	2.91e-05	0.000607	CcSEcCtD
Gemfibrozil—Pain—Orlistat—type 2 diabetes mellitus	2.91e-05	0.000607	CcSEcCtD
Gemfibrozil—Chest pain—Losartan—type 2 diabetes mellitus	2.9e-05	0.000606	CcSEcCtD
Gemfibrozil—Myalgia—Losartan—type 2 diabetes mellitus	2.9e-05	0.000606	CcSEcCtD
Gemfibrozil—Arthralgia—Losartan—type 2 diabetes mellitus	2.9e-05	0.000606	CcSEcCtD
Gemfibrozil—Vomiting—Bromocriptine—type 2 diabetes mellitus	2.9e-05	0.000605	CcSEcCtD
Gemfibrozil—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	2.9e-05	0.000605	CcSEcCtD
Gemfibrozil—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	2.89e-05	0.000604	CcSEcCtD
Gemfibrozil—Rash—Bromocriptine—type 2 diabetes mellitus	2.88e-05	0.0006	CcSEcCtD
Gemfibrozil—Dermatitis—Bromocriptine—type 2 diabetes mellitus	2.87e-05	0.0006	CcSEcCtD
Gemfibrozil—Skin disorder—Irbesartan—type 2 diabetes mellitus	2.87e-05	0.000599	CcSEcCtD
Gemfibrozil—Tension—Ramipril—type 2 diabetes mellitus	2.87e-05	0.000599	CcSEcCtD
Gemfibrozil—Dysgeusia—Ramipril—type 2 diabetes mellitus	2.86e-05	0.000597	CcSEcCtD
Gemfibrozil—Headache—Bromocriptine—type 2 diabetes mellitus	2.86e-05	0.000596	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	2.85e-05	0.000596	CcSEcCtD
Gemfibrozil—Diarrhoea—Glyburide—type 2 diabetes mellitus	2.85e-05	0.000596	CcSEcCtD
Gemfibrozil—Nervousness—Ramipril—type 2 diabetes mellitus	2.84e-05	0.000593	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	2.81e-05	0.000587	CcSEcCtD
Gemfibrozil—Paraesthesia—Metformin—type 2 diabetes mellitus	2.81e-05	0.000587	CcSEcCtD
Gemfibrozil—Confusional state—Losartan—type 2 diabetes mellitus	2.81e-05	0.000586	CcSEcCtD
Gemfibrozil—Feeling abnormal—Orlistat—type 2 diabetes mellitus	2.8e-05	0.000585	CcSEcCtD
Gemfibrozil—Somnolence—Metformin—type 2 diabetes mellitus	2.79e-05	0.000581	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Losartan—type 2 diabetes mellitus	2.78e-05	0.000581	CcSEcCtD
Gemfibrozil—Oedema—Losartan—type 2 diabetes mellitus	2.78e-05	0.000581	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	2.78e-05	0.00058	CcSEcCtD
Gemfibrozil—Dyspepsia—Metformin—type 2 diabetes mellitus	2.76e-05	0.000576	CcSEcCtD
Gemfibrozil—Shock—Losartan—type 2 diabetes mellitus	2.74e-05	0.000571	CcSEcCtD
Gemfibrozil—Urticaria—Valsartan—type 2 diabetes mellitus	2.73e-05	0.00057	CcSEcCtD
Gemfibrozil—Nervous system disorder—Losartan—type 2 diabetes mellitus	2.73e-05	0.00057	CcSEcCtD
Gemfibrozil—Thrombocytopenia—Losartan—type 2 diabetes mellitus	2.72e-05	0.000569	CcSEcCtD
Gemfibrozil—Abdominal pain—Valsartan—type 2 diabetes mellitus	2.72e-05	0.000568	CcSEcCtD
Gemfibrozil—Nausea—Bromocriptine—type 2 diabetes mellitus	2.71e-05	0.000566	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	2.7e-05	0.000565	CcSEcCtD
Gemfibrozil—Fatigue—Metformin—type 2 diabetes mellitus	2.7e-05	0.000564	CcSEcCtD
Gemfibrozil—Urticaria—Orlistat—type 2 diabetes mellitus	2.7e-05	0.000564	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	2.69e-05	0.000562	CcSEcCtD
Gemfibrozil—Abdominal pain—Orlistat—type 2 diabetes mellitus	2.69e-05	0.000561	CcSEcCtD
Gemfibrozil—Asthenia—Gliclazide—type 2 diabetes mellitus	2.69e-05	0.000561	CcSEcCtD
Gemfibrozil—Constipation—Metformin—type 2 diabetes mellitus	2.68e-05	0.000559	CcSEcCtD
Gemfibrozil—Angioedema—Ramipril—type 2 diabetes mellitus	2.67e-05	0.000557	CcSEcCtD
Gemfibrozil—Paraesthesia—Irbesartan—type 2 diabetes mellitus	2.65e-05	0.000554	CcSEcCtD
Gemfibrozil—Vomiting—Glyburide—type 2 diabetes mellitus	2.65e-05	0.000553	CcSEcCtD
Gemfibrozil—Pruritus—Gliclazide—type 2 diabetes mellitus	2.65e-05	0.000553	CcSEcCtD
Gemfibrozil—Rash—Glyburide—type 2 diabetes mellitus	2.63e-05	0.000549	CcSEcCtD
Gemfibrozil—Somnolence—Irbesartan—type 2 diabetes mellitus	2.63e-05	0.000549	CcSEcCtD
Gemfibrozil—Dermatitis—Glyburide—type 2 diabetes mellitus	2.63e-05	0.000548	CcSEcCtD
Gemfibrozil—Vertigo—Ramipril—type 2 diabetes mellitus	2.63e-05	0.000548	CcSEcCtD
Gemfibrozil—Syncope—Ramipril—type 2 diabetes mellitus	2.62e-05	0.000547	CcSEcCtD
Gemfibrozil—Leukopenia—Ramipril—type 2 diabetes mellitus	2.62e-05	0.000546	CcSEcCtD
Gemfibrozil—Headache—Glyburide—type 2 diabetes mellitus	2.61e-05	0.000545	CcSEcCtD
Gemfibrozil—Dyspepsia—Irbesartan—type 2 diabetes mellitus	2.6e-05	0.000543	CcSEcCtD
Gemfibrozil—Feeling abnormal—Metformin—type 2 diabetes mellitus	2.58e-05	0.000539	CcSEcCtD
Gemfibrozil—Loss of consciousness—Ramipril—type 2 diabetes mellitus	2.57e-05	0.000536	CcSEcCtD
Gemfibrozil—Diarrhoea—Gliclazide—type 2 diabetes mellitus	2.56e-05	0.000535	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	2.56e-05	0.000535	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	2.55e-05	0.000533	CcSEcCtD
Gemfibrozil—Cough—Ramipril—type 2 diabetes mellitus	2.55e-05	0.000532	CcSEcCtD
Gemfibrozil—Fatigue—Irbesartan—type 2 diabetes mellitus	2.55e-05	0.000532	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	2.53e-05	0.000529	CcSEcCtD
Gemfibrozil—Convulsion—Ramipril—type 2 diabetes mellitus	2.53e-05	0.000529	CcSEcCtD
Gemfibrozil—Pain—Irbesartan—type 2 diabetes mellitus	2.53e-05	0.000528	CcSEcCtD
Gemfibrozil—Constipation—Irbesartan—type 2 diabetes mellitus	2.53e-05	0.000528	CcSEcCtD
Gemfibrozil—Paraesthesia—Losartan—type 2 diabetes mellitus	2.5e-05	0.000521	CcSEcCtD
Gemfibrozil—Urticaria—Metformin—type 2 diabetes mellitus	2.49e-05	0.000519	CcSEcCtD
Gemfibrozil—Arthralgia—Ramipril—type 2 diabetes mellitus	2.49e-05	0.000519	CcSEcCtD
Gemfibrozil—Myalgia—Ramipril—type 2 diabetes mellitus	2.49e-05	0.000519	CcSEcCtD
Gemfibrozil—Chest pain—Ramipril—type 2 diabetes mellitus	2.49e-05	0.000519	CcSEcCtD
Gemfibrozil—Nausea—Glyburide—type 2 diabetes mellitus	2.48e-05	0.000517	CcSEcCtD
Gemfibrozil—Abdominal pain—Metformin—type 2 diabetes mellitus	2.48e-05	0.000517	CcSEcCtD
Gemfibrozil—Dizziness—Gliclazide—type 2 diabetes mellitus	2.48e-05	0.000517	CcSEcCtD
Gemfibrozil—Somnolence—Losartan—type 2 diabetes mellitus	2.47e-05	0.000516	CcSEcCtD
Gemfibrozil—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	2.47e-05	0.000516	CcSEcCtD
Gemfibrozil—Asthenia—Valsartan—type 2 diabetes mellitus	2.47e-05	0.000515	CcSEcCtD
Gemfibrozil—Dyspepsia—Losartan—type 2 diabetes mellitus	2.45e-05	0.000511	CcSEcCtD
Gemfibrozil—Asthenia—Orlistat—type 2 diabetes mellitus	2.44e-05	0.000509	CcSEcCtD
Gemfibrozil—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	2.44e-05	0.000509	CcSEcCtD
Gemfibrozil—Pruritus—Valsartan—type 2 diabetes mellitus	2.43e-05	0.000508	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	2.42e-05	0.000505	CcSEcCtD
Gemfibrozil—Confusional state—Ramipril—type 2 diabetes mellitus	2.41e-05	0.000502	CcSEcCtD
Gemfibrozil—Pruritus—Orlistat—type 2 diabetes mellitus	2.41e-05	0.000502	CcSEcCtD
Gemfibrozil—Fatigue—Losartan—type 2 diabetes mellitus	2.4e-05	0.000501	CcSEcCtD
Gemfibrozil—Oedema—Ramipril—type 2 diabetes mellitus	2.39e-05	0.000498	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	2.39e-05	0.000498	CcSEcCtD
Gemfibrozil—Vomiting—Gliclazide—type 2 diabetes mellitus	2.38e-05	0.000497	CcSEcCtD
Gemfibrozil—Pain—Losartan—type 2 diabetes mellitus	2.38e-05	0.000497	CcSEcCtD
Gemfibrozil—Constipation—Losartan—type 2 diabetes mellitus	2.38e-05	0.000497	CcSEcCtD
Gemfibrozil—Rash—Gliclazide—type 2 diabetes mellitus	2.36e-05	0.000493	CcSEcCtD
Gemfibrozil—Dermatitis—Gliclazide—type 2 diabetes mellitus	2.36e-05	0.000492	CcSEcCtD
Gemfibrozil—Diarrhoea—Valsartan—type 2 diabetes mellitus	2.35e-05	0.000491	CcSEcCtD
Gemfibrozil—Urticaria—Irbesartan—type 2 diabetes mellitus	2.35e-05	0.00049	CcSEcCtD
Gemfibrozil—Shock—Ramipril—type 2 diabetes mellitus	2.35e-05	0.00049	CcSEcCtD
Gemfibrozil—Headache—Gliclazide—type 2 diabetes mellitus	2.35e-05	0.00049	CcSEcCtD
Gemfibrozil—Nervous system disorder—Ramipril—type 2 diabetes mellitus	2.34e-05	0.000488	CcSEcCtD
Gemfibrozil—Abdominal pain—Irbesartan—type 2 diabetes mellitus	2.34e-05	0.000488	CcSEcCtD
Gemfibrozil—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	2.34e-05	0.000488	CcSEcCtD
Gemfibrozil—Diarrhoea—Orlistat—type 2 diabetes mellitus	2.33e-05	0.000485	CcSEcCtD
Gemfibrozil—Skin disorder—Ramipril—type 2 diabetes mellitus	2.32e-05	0.000484	CcSEcCtD
Gemfibrozil—Feeling abnormal—Losartan—type 2 diabetes mellitus	2.29e-05	0.000479	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	2.28e-05	0.000475	CcSEcCtD
Gemfibrozil—Dizziness—Valsartan—type 2 diabetes mellitus	2.28e-05	0.000475	CcSEcCtD
Gemfibrozil—Dizziness—Orlistat—type 2 diabetes mellitus	2.25e-05	0.000469	CcSEcCtD
Gemfibrozil—Asthenia—Metformin—type 2 diabetes mellitus	2.25e-05	0.000469	CcSEcCtD
Gemfibrozil—Nausea—Gliclazide—type 2 diabetes mellitus	2.22e-05	0.000464	CcSEcCtD
Gemfibrozil—Pruritus—Metformin—type 2 diabetes mellitus	2.22e-05	0.000463	CcSEcCtD
Gemfibrozil—Urticaria—Losartan—type 2 diabetes mellitus	2.21e-05	0.000461	CcSEcCtD
Gemfibrozil—Abdominal pain—Losartan—type 2 diabetes mellitus	2.2e-05	0.000459	CcSEcCtD
Gemfibrozil—Vomiting—Valsartan—type 2 diabetes mellitus	2.19e-05	0.000457	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	2.17e-05	0.000454	CcSEcCtD
Gemfibrozil—Rash—Valsartan—type 2 diabetes mellitus	2.17e-05	0.000453	CcSEcCtD
Gemfibrozil—Dermatitis—Valsartan—type 2 diabetes mellitus	2.17e-05	0.000452	CcSEcCtD
Gemfibrozil—Vomiting—Orlistat—type 2 diabetes mellitus	2.16e-05	0.000451	CcSEcCtD
Gemfibrozil—Headache—Valsartan—type 2 diabetes mellitus	2.16e-05	0.00045	CcSEcCtD
Gemfibrozil—Diarrhoea—Metformin—type 2 diabetes mellitus	2.14e-05	0.000447	CcSEcCtD
Gemfibrozil—Rash—Orlistat—type 2 diabetes mellitus	2.14e-05	0.000447	CcSEcCtD
Gemfibrozil—Paraesthesia—Ramipril—type 2 diabetes mellitus	2.14e-05	0.000447	CcSEcCtD
Gemfibrozil—Dermatitis—Orlistat—type 2 diabetes mellitus	2.14e-05	0.000447	CcSEcCtD
Gemfibrozil—Headache—Orlistat—type 2 diabetes mellitus	2.13e-05	0.000444	CcSEcCtD
Gemfibrozil—Asthenia—Irbesartan—type 2 diabetes mellitus	2.12e-05	0.000443	CcSEcCtD
Gemfibrozil—Somnolence—Ramipril—type 2 diabetes mellitus	2.12e-05	0.000443	CcSEcCtD
Gemfibrozil—Dyspepsia—Ramipril—type 2 diabetes mellitus	2.1e-05	0.000438	CcSEcCtD
Gemfibrozil—Pruritus—Irbesartan—type 2 diabetes mellitus	2.09e-05	0.000437	CcSEcCtD
Gemfibrozil—Dizziness—Metformin—type 2 diabetes mellitus	2.07e-05	0.000432	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	2.06e-05	0.00043	CcSEcCtD
Gemfibrozil—Fatigue—Ramipril—type 2 diabetes mellitus	2.06e-05	0.000429	CcSEcCtD
Gemfibrozil—Nausea—Valsartan—type 2 diabetes mellitus	2.04e-05	0.000427	CcSEcCtD
Gemfibrozil—Constipation—Ramipril—type 2 diabetes mellitus	2.04e-05	0.000426	CcSEcCtD
Gemfibrozil—Diarrhoea—Irbesartan—type 2 diabetes mellitus	2.02e-05	0.000422	CcSEcCtD
Gemfibrozil—Nausea—Orlistat—type 2 diabetes mellitus	2.02e-05	0.000421	CcSEcCtD
Gemfibrozil—Asthenia—Losartan—type 2 diabetes mellitus	2e-05	0.000417	CcSEcCtD
Gemfibrozil—Vomiting—Metformin—type 2 diabetes mellitus	1.99e-05	0.000416	CcSEcCtD
Gemfibrozil—Rash—Metformin—type 2 diabetes mellitus	1.98e-05	0.000412	CcSEcCtD
Gemfibrozil—Dermatitis—Metformin—type 2 diabetes mellitus	1.97e-05	0.000412	CcSEcCtD
Gemfibrozil—Pruritus—Losartan—type 2 diabetes mellitus	1.97e-05	0.000411	CcSEcCtD
Gemfibrozil—Feeling abnormal—Ramipril—type 2 diabetes mellitus	1.97e-05	0.00041	CcSEcCtD
Gemfibrozil—Headache—Metformin—type 2 diabetes mellitus	1.96e-05	0.00041	CcSEcCtD
Gemfibrozil—Dizziness—Irbesartan—type 2 diabetes mellitus	1.96e-05	0.000408	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	1.95e-05	0.000407	CcSEcCtD
Gemfibrozil—Diarrhoea—Losartan—type 2 diabetes mellitus	1.9e-05	0.000397	CcSEcCtD
Gemfibrozil—Urticaria—Ramipril—type 2 diabetes mellitus	1.9e-05	0.000396	CcSEcCtD
Gemfibrozil—Abdominal pain—Ramipril—type 2 diabetes mellitus	1.89e-05	0.000394	CcSEcCtD
Gemfibrozil—Vomiting—Irbesartan—type 2 diabetes mellitus	1.88e-05	0.000392	CcSEcCtD
Gemfibrozil—Rash—Irbesartan—type 2 diabetes mellitus	1.86e-05	0.000389	CcSEcCtD
Gemfibrozil—Dermatitis—Irbesartan—type 2 diabetes mellitus	1.86e-05	0.000389	CcSEcCtD
Gemfibrozil—Nausea—Metformin—type 2 diabetes mellitus	1.86e-05	0.000388	CcSEcCtD
Gemfibrozil—Headache—Irbesartan—type 2 diabetes mellitus	1.85e-05	0.000387	CcSEcCtD
Gemfibrozil—Dizziness—Losartan—type 2 diabetes mellitus	1.84e-05	0.000384	CcSEcCtD
Gemfibrozil—Vomiting—Losartan—type 2 diabetes mellitus	1.77e-05	0.000369	CcSEcCtD
Gemfibrozil—Nausea—Irbesartan—type 2 diabetes mellitus	1.76e-05	0.000367	CcSEcCtD
Gemfibrozil—Rash—Losartan—type 2 diabetes mellitus	1.75e-05	0.000366	CcSEcCtD
Gemfibrozil—Dermatitis—Losartan—type 2 diabetes mellitus	1.75e-05	0.000366	CcSEcCtD
Gemfibrozil—Headache—Losartan—type 2 diabetes mellitus	1.74e-05	0.000364	CcSEcCtD
Gemfibrozil—Asthenia—Ramipril—type 2 diabetes mellitus	1.71e-05	0.000357	CcSEcCtD
Gemfibrozil—Pruritus—Ramipril—type 2 diabetes mellitus	1.69e-05	0.000352	CcSEcCtD
Gemfibrozil—Nausea—Losartan—type 2 diabetes mellitus	1.65e-05	0.000345	CcSEcCtD
Gemfibrozil—Diarrhoea—Ramipril—type 2 diabetes mellitus	1.63e-05	0.000341	CcSEcCtD
Gemfibrozil—Dizziness—Ramipril—type 2 diabetes mellitus	1.58e-05	0.000329	CcSEcCtD
Gemfibrozil—Vomiting—Ramipril—type 2 diabetes mellitus	1.52e-05	0.000317	CcSEcCtD
Gemfibrozil—Rash—Ramipril—type 2 diabetes mellitus	1.5e-05	0.000314	CcSEcCtD
Gemfibrozil—Dermatitis—Ramipril—type 2 diabetes mellitus	1.5e-05	0.000314	CcSEcCtD
Gemfibrozil—Headache—Ramipril—type 2 diabetes mellitus	1.49e-05	0.000312	CcSEcCtD
Gemfibrozil—Nausea—Ramipril—type 2 diabetes mellitus	1.42e-05	0.000296	CcSEcCtD
Gemfibrozil—CYP2C8—Metabolism—HMGCR—type 2 diabetes mellitus	1.8e-06	6.74e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—SLC9A1—type 2 diabetes mellitus	1.8e-06	6.73e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—CETP—type 2 diabetes mellitus	1.78e-06	6.66e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	1.78e-06	6.65e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	1.77e-06	6.61e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	1.77e-06	6.61e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—ADRA2A—type 2 diabetes mellitus	1.77e-06	6.6e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—SLC2A2—type 2 diabetes mellitus	1.76e-06	6.59e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	1.74e-06	6.51e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—ALDOB—type 2 diabetes mellitus	1.74e-06	6.49e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—CPT1A—type 2 diabetes mellitus	1.73e-06	6.45e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—MTR—type 2 diabetes mellitus	1.73e-06	6.45e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	1.7e-06	6.36e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	1.7e-06	6.36e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—CYP2E1—type 2 diabetes mellitus	1.7e-06	6.34e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—NAMPT—type 2 diabetes mellitus	1.69e-06	6.33e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	1.69e-06	6.3e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	1.68e-06	6.29e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—GCK—type 2 diabetes mellitus	1.68e-06	6.29e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—HBA1—type 2 diabetes mellitus	1.68e-06	6.29e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—LIPC—type 2 diabetes mellitus	1.68e-06	6.29e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—CYP1A2—type 2 diabetes mellitus	1.68e-06	6.27e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—SLC2A1—type 2 diabetes mellitus	1.68e-06	6.27e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—CYP11A1—type 2 diabetes mellitus	1.67e-06	6.25e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	1.67e-06	6.25e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	1.66e-06	6.21e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—PSMD6—type 2 diabetes mellitus	1.66e-06	6.19e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—SNAP25—type 2 diabetes mellitus	1.66e-06	6.19e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—SREBF1—type 2 diabetes mellitus	1.66e-06	6.19e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	1.65e-06	6.17e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	1.64e-06	6.14e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	1.64e-06	6.14e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	1.64e-06	6.14e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—SLC9A1—type 2 diabetes mellitus	1.64e-06	6.14e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—CYP3A4—type 2 diabetes mellitus	1.64e-06	6.11e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	1.63e-06	6.1e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	1.63e-06	6.08e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—CTGF—type 2 diabetes mellitus	1.62e-06	6.07e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—CETP—type 2 diabetes mellitus	1.62e-06	6.07e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—GLP1R—type 2 diabetes mellitus	1.61e-06	6.03e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—HMGCR—type 2 diabetes mellitus	1.61e-06	6.02e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—SLC2A4—type 2 diabetes mellitus	1.61e-06	6.01e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—GCG—type 2 diabetes mellitus	1.61e-06	6.01e-05	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—PPARG—type 2 diabetes mellitus	1.6e-06	5.99e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	1.59e-06	5.94e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—ADRA2A—type 2 diabetes mellitus	1.58e-06	5.89e-05	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—INS—type 2 diabetes mellitus	1.57e-06	5.88e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	1.54e-06	5.77e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—CYP2E1—type 2 diabetes mellitus	1.51e-06	5.66e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	1.51e-06	5.66e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—PSMD6—type 2 diabetes mellitus	1.51e-06	5.64e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—SNAP25—type 2 diabetes mellitus	1.51e-06	5.64e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—SREBF1—type 2 diabetes mellitus	1.51e-06	5.64e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—SLC2A2—type 2 diabetes mellitus	1.51e-06	5.63e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—SLC2A1—type 2 diabetes mellitus	1.5e-06	5.6e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—CYP1A2—type 2 diabetes mellitus	1.5e-06	5.6e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—CTGF—type 2 diabetes mellitus	1.48e-06	5.54e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—CPT1A—type 2 diabetes mellitus	1.48e-06	5.52e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—MTR—type 2 diabetes mellitus	1.48e-06	5.52e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—HMGCR—type 2 diabetes mellitus	1.47e-06	5.49e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—CYP3A4—type 2 diabetes mellitus	1.46e-06	5.46e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	1.45e-06	5.43e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	1.45e-06	5.41e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—NAMPT—type 2 diabetes mellitus	1.45e-06	5.41e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	1.45e-06	5.41e-05	CbGpPWpGaD
Gemfibrozil—PPARA—Gene Expression—AKT1—type 2 diabetes mellitus	1.44e-06	5.4e-05	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—ALB—type 2 diabetes mellitus	1.44e-06	5.39e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	1.44e-06	5.38e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—HBA1—type 2 diabetes mellitus	1.44e-06	5.37e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—LIPC—type 2 diabetes mellitus	1.44e-06	5.37e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—GCK—type 2 diabetes mellitus	1.44e-06	5.37e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—ADRA2A—type 2 diabetes mellitus	1.44e-06	5.37e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—SLC2A4—type 2 diabetes mellitus	1.44e-06	5.36e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—GCG—type 2 diabetes mellitus	1.44e-06	5.36e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—CYP11A1—type 2 diabetes mellitus	1.43e-06	5.34e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—SLC9A1—type 2 diabetes mellitus	1.4e-06	5.25e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	1.4e-06	5.22e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	1.4e-06	5.22e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	1.4e-06	5.22e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	1.4e-06	5.22e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—CETP—type 2 diabetes mellitus	1.39e-06	5.19e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—GNB3—type 2 diabetes mellitus	1.39e-06	5.18e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.39e-06	5.18e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—CYP2E1—type 2 diabetes mellitus	1.38e-06	5.16e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—HMOX1—type 2 diabetes mellitus	1.38e-06	5.16e-05	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—NOS3—type 2 diabetes mellitus	1.38e-06	5.15e-05	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—PIK3R1—type 2 diabetes mellitus	1.38e-06	5.15e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—SLC2A1—type 2 diabetes mellitus	1.36e-06	5.1e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—CYP1A2—type 2 diabetes mellitus	1.36e-06	5.1e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—CAT—type 2 diabetes mellitus	1.36e-06	5.09e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	1.34e-06	5.01e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—CYP3A4—type 2 diabetes mellitus	1.33e-06	4.98e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	1.32e-06	4.95e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—APOB—type 2 diabetes mellitus	1.32e-06	4.94e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—SLC2A4—type 2 diabetes mellitus	1.31e-06	4.89e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—GCG—type 2 diabetes mellitus	1.31e-06	4.89e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	1.29e-06	4.83e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—PSMD6—type 2 diabetes mellitus	1.29e-06	4.82e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—SNAP25—type 2 diabetes mellitus	1.29e-06	4.82e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—SREBF1—type 2 diabetes mellitus	1.29e-06	4.82e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—GSTM1—type 2 diabetes mellitus	1.29e-06	4.8e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—CTGF—type 2 diabetes mellitus	1.27e-06	4.73e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—LPL—type 2 diabetes mellitus	1.26e-06	4.72e-05	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—PTGS2—type 2 diabetes mellitus	1.26e-06	4.71e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—HMGCR—type 2 diabetes mellitus	1.25e-06	4.69e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	1.25e-06	4.65e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	1.24e-06	4.62e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.24e-06	4.62e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—GNB3—type 2 diabetes mellitus	1.24e-06	4.62e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—ADCY5—type 2 diabetes mellitus	1.24e-06	4.62e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—HMOX1—type 2 diabetes mellitus	1.23e-06	4.6e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—GPX1—type 2 diabetes mellitus	1.23e-06	4.6e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—ADRA2A—type 2 diabetes mellitus	1.23e-06	4.59e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—CAT—type 2 diabetes mellitus	1.21e-06	4.54e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—CD36—type 2 diabetes mellitus	1.2e-06	4.48e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—PPP2CA—type 2 diabetes mellitus	1.18e-06	4.42e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—CYP2E1—type 2 diabetes mellitus	1.18e-06	4.41e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—APOB—type 2 diabetes mellitus	1.18e-06	4.41e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—SLC2A1—type 2 diabetes mellitus	1.17e-06	4.36e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	1.16e-06	4.34e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—GSTM1—type 2 diabetes mellitus	1.15e-06	4.29e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	1.14e-06	4.26e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	1.14e-06	4.26e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—CYP3A4—type 2 diabetes mellitus	1.14e-06	4.25e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—MTHFR—type 2 diabetes mellitus	1.14e-06	4.25e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	1.13e-06	4.23e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—GNB3—type 2 diabetes mellitus	1.13e-06	4.22e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.13e-06	4.22e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—LPL—type 2 diabetes mellitus	1.13e-06	4.21e-05	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—AKT1—type 2 diabetes mellitus	1.12e-06	4.2e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—HMOX1—type 2 diabetes mellitus	1.12e-06	4.2e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—GCG—type 2 diabetes mellitus	1.12e-06	4.18e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—SLC2A4—type 2 diabetes mellitus	1.12e-06	4.18e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	1.12e-06	4.17e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—PPARA—type 2 diabetes mellitus	1.11e-06	4.17e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	1.11e-06	4.15e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	1.11e-06	4.15e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	1.11e-06	4.15e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—CAT—type 2 diabetes mellitus	1.11e-06	4.14e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	1.1e-06	4.12e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—ADCY5—type 2 diabetes mellitus	1.1e-06	4.12e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—GPX1—type 2 diabetes mellitus	1.1e-06	4.11e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	1.08e-06	4.05e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—AGT—type 2 diabetes mellitus	1.08e-06	4.03e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—APOB—type 2 diabetes mellitus	1.08e-06	4.02e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	1.07e-06	4e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—CD36—type 2 diabetes mellitus	1.07e-06	4e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—CALM1—type 2 diabetes mellitus	1.06e-06	3.97e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—APOE—type 2 diabetes mellitus	1.06e-06	3.95e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—PPP2CA—type 2 diabetes mellitus	1.06e-06	3.95e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—GSTM1—type 2 diabetes mellitus	1.05e-06	3.91e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—APOA1—type 2 diabetes mellitus	1.05e-06	3.91e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—LPL—type 2 diabetes mellitus	1.03e-06	3.84e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—MTHFR—type 2 diabetes mellitus	1.01e-06	3.79e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—ADCY5—type 2 diabetes mellitus	1.01e-06	3.76e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—GPX1—type 2 diabetes mellitus	1e-06	3.74e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	9.95e-07	3.72e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	9.95e-07	3.72e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	9.95e-07	3.72e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—PPARA—type 2 diabetes mellitus	9.95e-07	3.72e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	9.77e-07	3.65e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—CD36—type 2 diabetes mellitus	9.76e-07	3.65e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	9.68e-07	3.62e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—GNB3—type 2 diabetes mellitus	9.64e-07	3.6e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—PPARGC1A—type 2 diabetes mellitus	9.64e-07	3.6e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—PPP2CA—type 2 diabetes mellitus	9.63e-07	3.6e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—AGT—type 2 diabetes mellitus	9.63e-07	3.6e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—HMOX1—type 2 diabetes mellitus	9.59e-07	3.59e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	9.48e-07	3.54e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—CALM1—type 2 diabetes mellitus	9.47e-07	3.54e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—CAT—type 2 diabetes mellitus	9.47e-07	3.54e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—APOE—type 2 diabetes mellitus	9.44e-07	3.53e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—APOA1—type 2 diabetes mellitus	9.33e-07	3.49e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—MTHFR—type 2 diabetes mellitus	9.25e-07	3.46e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—PPARG—type 2 diabetes mellitus	9.21e-07	3.44e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—APOB—type 2 diabetes mellitus	9.19e-07	3.44e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	9.1e-07	3.4e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—PPARA—type 2 diabetes mellitus	9.07e-07	3.39e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—INS—type 2 diabetes mellitus	9.03e-07	3.38e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	9e-07	3.36e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	9e-07	3.36e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—GSTM1—type 2 diabetes mellitus	8.94e-07	3.34e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—AGT—type 2 diabetes mellitus	8.78e-07	3.28e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—LPL—type 2 diabetes mellitus	8.77e-07	3.28e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	8.64e-07	3.23e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	8.63e-07	3.23e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	8.63e-07	3.23e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	8.61e-07	3.22e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—ADCY5—type 2 diabetes mellitus	8.59e-07	3.21e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—GPX1—type 2 diabetes mellitus	8.56e-07	3.2e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	8.51e-07	3.18e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—CD36—type 2 diabetes mellitus	8.34e-07	3.12e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—ALB—type 2 diabetes mellitus	8.28e-07	3.1e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—PPP2CA—type 2 diabetes mellitus	8.23e-07	3.08e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—PPARG—type 2 diabetes mellitus	8.22e-07	3.07e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—INS—type 2 diabetes mellitus	8.06e-07	3.01e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—NOS3—type 2 diabetes mellitus	7.92e-07	2.96e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—PIK3R1—type 2 diabetes mellitus	7.92e-07	2.96e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—MTHFR—type 2 diabetes mellitus	7.9e-07	2.95e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—PPARA—type 2 diabetes mellitus	7.75e-07	2.9e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—AGT—type 2 diabetes mellitus	7.51e-07	2.81e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	7.5e-07	2.8e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	7.44e-07	2.78e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	7.44e-07	2.78e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	7.4e-07	2.77e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—ALB—type 2 diabetes mellitus	7.39e-07	2.76e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—CALM1—type 2 diabetes mellitus	7.38e-07	2.76e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—APOE—type 2 diabetes mellitus	7.36e-07	2.75e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	7.35e-07	2.75e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	7.31e-07	2.73e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—APOA1—type 2 diabetes mellitus	7.27e-07	2.72e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—PTGS2—type 2 diabetes mellitus	7.25e-07	2.71e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	7.09e-07	2.65e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—PIK3R1—type 2 diabetes mellitus	7.07e-07	2.64e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—NOS3—type 2 diabetes mellitus	7.07e-07	2.64e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	6.9e-07	2.58e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	6.77e-07	2.53e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	6.74e-07	2.52e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	6.63e-07	2.48e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	6.61e-07	2.47e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—PTGS2—type 2 diabetes mellitus	6.47e-07	2.42e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	6.45e-07	2.41e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	6.45e-07	2.41e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	6.43e-07	2.41e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—PPARG—type 2 diabetes mellitus	6.41e-07	2.39e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	6.35e-07	2.38e-05	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—AKT1—type 2 diabetes mellitus	6.34e-07	2.37e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—INS—type 2 diabetes mellitus	6.28e-07	2.35e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	6.1e-07	2.28e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	5.98e-07	2.24e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	5.9e-07	2.2e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	5.79e-07	2.17e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—ALB—type 2 diabetes mellitus	5.76e-07	2.15e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	5.7e-07	2.13e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	5.68e-07	2.12e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	5.61e-07	2.1e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	5.51e-07	2.06e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—NOS3—type 2 diabetes mellitus	5.51e-07	2.06e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—PTGS2—type 2 diabetes mellitus	5.04e-07	1.88e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	4.94e-07	1.85e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	4.85e-07	1.81e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	4.45e-07	1.66e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	4.25e-07	1.59e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	4.25e-07	1.59e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	3.89e-07	1.45e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—AKT1—type 2 diabetes mellitus	3.64e-07	1.36e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—AKT1—type 2 diabetes mellitus	3.25e-07	1.22e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	2.96e-07	1.11e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—AKT1—type 2 diabetes mellitus	2.53e-07	9.47e-06	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	1.95e-07	7.31e-06	CbGpPWpGaD
